LOGAN, Utah, May 2 /PRNewswire/ -- Facet Solutions, Inc., a privately held company focused on commercializing motion preservation spinal implants, today announced the addition of industry veteran Mr. Mike McCarthy to serve on its Board of Directors.
"Mr. McCarthy is a terrific addition to our Board, bringing a wealth of knowledge in the spine industry which will assist Facet Solutions throughout the clinical and commercialization phases of the company," stated Mr. Geoff Pardo, President and CEO of Facet Solutions, Inc. "Mr. McCarthy has exhibited a track record of success, most recently as President and CEO of Endius which was sold to Zimmer in 2007. Throughout his 29 year orthopedic and spine industry career he has held many executive level positions, including Global Vice President of Sales and Marketing for Implex through its acquisition by Zimmer and several executive positions with Johnson & Johnson."
Mr. McCarthy provided his perspective on being appointed to the Facet Solutions Board. "I am a huge fan of Facet Solutions. They have all of the ingredients of a great company which include a large market opportunity, great technology, leading intellectual property and a fantastic team. I look forward to working with the Facet Solutions Board and management team to bring breakthrough technologies to the lumbar spine marketplace."
Facet Solutions, Inc. has developed the Anatomic Facet Replacement System (AFRS(TM)) to provide patients with lumbar spinal stenosis and facet degeneration, a motion preserving alternative to lumbar spinal fusion. The AFRS(TM) procedure includes replacement of the diseased facet joint with an anatomic implant that restores the natural motion, stability, and balance to the lumbar spine.
*Note: AFRS(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.
About Facet Solutions
Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.
|SOURCE Facet Solutions, Inc.|
Copyright©2008 PR Newswire.
All rights reserved